Caxton Corp Xeris Biopharma Holdings, Inc. Transaction History
Caxton Corp
- $16.2 Million
- Q1 2024
A detailed history of Caxton Corp transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Caxton Corp holds 5,113,348 shares of XERS stock, worth $10.6 Million. This represents 69.8% of its overall portfolio holdings.
Number of Shares
5,113,348
Previous 5,641,920
9.37%
Holding current value
$10.6 Million
Previous $13.3 Million
14.77%
% of portfolio
69.8%
Previous 76.39%
Shares
4 transactions
Others Institutions Holding XERS
# of Institutions
143Shares Held
57.3MCall Options Held
87.6KPut Options Held
80.4K-
Black Rock Inc. New York, NY9.96MShares$20.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.61MShares$15.8 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.17MShares$8.67 Million1.51% of portfolio
-
State Street Corp Boston, MA3.22MShares$6.69 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.05MShares$6.33 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $283M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...